跳至主要内容
临床试验/RPCEC00000378
RPCEC00000378尚未招募4 期

Effects of policosanol + aspirin therapy on cognitive impairment in patients with ischemic stroke. - Poli/ASA-DC-IC

ational Center for Scientific Research0 个研究点目标入组 100 人开始时间: 2021年6月30日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled trial. Masking: Double Blind. Control group: Placebo. Assignment: Parallel. Purpose: Treatment

入排标准

年龄范围
60 years 至 one(—)
性别
All

入选标准

  • 1) Patients of both sexes,
  • 2) Patients older or equal than 60 years of age.
  • 3) Documented history of having suffered an ischemic stroke (diagnosed in the previous 30 days),
  • 4) Who do not present evidence of cognitive decline (according to the questionnaire to be applied on the cognitive state of the patient),
  • 5) With Rankin Scale values greater or equal than 2, less or equal than 5 (2-5),
  • 6) Who agree to participate in the study by signing the informed consent.

排除标准

  • Patients with:
  • 1) Diagnosed neoplasms,
  • 2) Atrial fibrillation,
  • 3) Diastolic hypertension 110 mm Hg,
  • 4) History of hemorrhagic stroke or subarachnoid hemorrhage,
  • 5) Heart valves,
  • 6) History of myocardial infarction, unstable angina, or revascularization in the previous 6 months,
  • 7) Any other special condition that, in the opinion of the doctor, puts your health and life at risk during the study.

研究者

发起方
ational Center for Scientific Research

相似试验